Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Patients 1 Year of Age and Over With GSD III

Trial Information
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
Summary

The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).

Am I eligible for this trial?
Participation Requirements
Sex:
All
Minimum Age:
1
Healthy Volunteers:
No

• Diagnosis of GSD III, confirmed by amylo-alpha-1,6-glucosidase 4-alpha-glucanotransferase (AGL) sequencing or glycogen debranching enzyme (GDE) enzymatic testing

Where is this trial taking place?
United States
Pennsylvania
Children's Hospital of Philadelphia
Recruiting
Philadelphia
Texas
University of Texas
Recruiting
Houston
Who do I contact about this trial?
Primary
Patients Contact: Trial Recruitment
TrialRecruitment@ultragenyx.com
1-888-756-8657
Backup
HCPs Contact: Medical Information
medinfo@ultragenyx.com
1-888-756-8657
When is this trial taking place?
Start Date: May 20, 2022
Estimated Completion Date: February 2023
How many participants will be in this trial?
Target number of participants: 25
What other conditions are being studied in this trial?
Glycogen Storage Disease Type 3
Low Blood Sugar
Pompe Disease

This content was sourced from clinicaltrials.gov

Similar Clinical Trials
A Randomized, Double-blind, Vehicle-Controlled, Seamless and Adaptive-designed Phase II/III Study to Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Adult and Adolescent Patients With Mild-to-Moderate Atopic Dermatitis
Who is this study for:Adult and adolescent patients with Moderate to Severe Atopic Dermatitis
Status:Recruiting
Start Date:December 30, 2020
Study Drug:SHR0302
Study Type:Drug
Phase: Phase 2/Phase 3
Explore this trial
Epidemiology, Approaches to the Diagnosis and Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia
Status:Recruiting
Start Date:January 10, 2020
Explore this trial
A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma-Derived Anti-thrombin III Concentrate With Administration in Surgery, Pregnancy and Thromboembolic or Thrombotic Events
Status:Active, not recruiting
Start Date:January 2006
Study Type:Drug
Phase: Phase 2/Phase 3
Explore this trial